Bio Protocol vs Zilliqa — how do they compare? Bio Protocol trades at Rp431.94 (market cap Rp969,79M, Rp153,24M 24h volume), while Zilliqa trades at Rp41.03 (market cap Rp815,96M, Rp70,46M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 20,1B / 21B ZIL (96%) for Zilliqa. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Zilliqa for 130 Days on average.
| BIO | ZIL | |
|---|---|---|
Market Cap | Rp969,79M | Rp815,96M |
Volume (24h) | Rp153,24M | Rp70,46M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 20,1B / 21B ZIL (96%) |
Typical Hold Time | 18 Days | 130 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Zilliqa (ZIL) is currently trading at Rp42.489 with a bearish technical signal, as indicated by moving averages, though oscillators are neutral. The token is near its 52-week low, with key support at Rp40 and resistance at Rp43. On-chain metrics show a high circulation rate of 96%, with an average hold time of 130 days. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious due to bearish technicals and lack of positive catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks involve continued downward pressure, low liquidity, and broader crypto market volatility. Investors should monitor for any network upgrades or increased adoption to shift sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Zilliqa (ZIL) is a public, permissionless blockchain that is designed to offer high throughput with the ability to complete thousands of transactions per second. It seeks to solve the issue of blockchain scalability and speed by employing sharding as a second-layer scaling solution. The platform is home to many decentralized applications, and as of October 2020, it also allows for staking and yield farming.
Read more on ZIL →